291 related articles for article (PubMed ID: 28825265)
21. In vivo susceptibility of ESBL producing Escherichia coli to ceftriaxone in children with acute pyelonephritis.
Peco-Antić A; Paripović D; Buljugić S; Spasojević-Dimitrijeva B; Cvetković M; Laban-Nestorović S; Milosevski-Lomić G
Srp Arh Celok Lek; 2012; 140(5-6):321-5. PubMed ID: 22826985
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis.
Chang UI; Kim HW; Wie SH
Yonsei Med J; 2015 Sep; 56(5):1266-73. PubMed ID: 26256969
[TBL] [Abstract][Full Text] [Related]
23. Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high.
Jeon JH; Kim K; Han WD; Song SH; Park KU; Rhee JE; Song KH; Park WB; Kim ES; Park SW; Kim NJ; Oh MD; Kim HB
Antimicrob Agents Chemother; 2012 Jun; 56(6):3043-6. PubMed ID: 22391544
[TBL] [Abstract][Full Text] [Related]
24. Clinical implication of serum C-reactive protein in patients with uncomplicated acute pyelonephritis as marker of prolonged hospitalization and recurrence.
Yang WJ; Cho IR; Seong do H; Song YS; Lee DH; Song KH; Cho KS; Sung Hong W; Kim HS
Urology; 2009 Jan; 73(1):19-22. PubMed ID: 18930516
[TBL] [Abstract][Full Text] [Related]
25. Impact of extended-spectrum β-lactamase production on treatment outcomes of acute pyelonephritis caused by escherichia coli in patients without health care-associated risk factors.
Park SH; Choi SM; Lee DG; Cho SY; Lee HJ; Choi JK; Choi JH; Yoo JH
Antimicrob Agents Chemother; 2015 Apr; 59(4):1962-8. PubMed ID: 25583722
[TBL] [Abstract][Full Text] [Related]
26. Clinical and microbiological characteristics of female patients with acute pyelonephritis who experienced urinary tract infections within the previous year.
Yoon C; Kim J; Jang W; Ko JW; Kim J; Pai H; Lee Y; Kim B
J Infect Public Health; 2024 Feb; 17(2):349-358. PubMed ID: 38198967
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis.
Chang UI; Kim HW; Noh YS; Wie SH
Korean J Intern Med; 2015 May; 30(3):372-83. PubMed ID: 25995668
[TBL] [Abstract][Full Text] [Related]
28. The lack of association between age and diabetes and hospitalization in women with acute pyelonephritis.
Rhee JE; Kim K; Lee CC; Kang J; Lee JW; Shin JH; Suh G; Singer AJ
J Emerg Med; 2011 Jul; 41(1):29-34. PubMed ID: 18996670
[TBL] [Abstract][Full Text] [Related]
29. Are blood cultures necessary in the management of women with complicated pyelonephritis?
Chen Y; Nitzan O; Saliba W; Chazan B; Colodner R; Raz R
J Infect; 2006 Oct; 53(4):235-40. PubMed ID: 16434102
[TBL] [Abstract][Full Text] [Related]
30. Comparison of antimicrobial resistance in patients with obstructive pyelonephritis associated with ureteral stones and uncomplicated pyelonephritis.
Jang YR; Won J; Han J; Chung W; Ahn SJ
Medicine (Baltimore); 2022 Aug; 101(34):e30376. PubMed ID: 36042611
[TBL] [Abstract][Full Text] [Related]
31. The role of emergency ultrasound for evaluating acute pyelonephritis in the ED.
Chen KC; Hung SW; Seow VK; Chong CF; Wang TL; Li YC; Chang H
Am J Emerg Med; 2011 Sep; 29(7):721-4. PubMed ID: 20825875
[TBL] [Abstract][Full Text] [Related]
32. The effect of an observation unit on the rate of ED admission and discharge for pyelonephritis.
Schrock JW; Reznikova S; Weller S
Am J Emerg Med; 2010 Jul; 28(6):682-8. PubMed ID: 20637383
[TBL] [Abstract][Full Text] [Related]
33. Microbiological Spectrum and Outcomes of Acute Pyelonephritis in North Indian Population.
Hase AN; Bansal SB; Gadde AB; Nandwani A
Saudi J Kidney Dis Transpl; 2021; 32(1):209-217. PubMed ID: 34145133
[TBL] [Abstract][Full Text] [Related]
34. Clinical effectiveness of oral antimicrobial therapy for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales.
Kim SH; Lim KR; Lee H; Huh K; Cho SY; Kang CI; Chung DR; Peck KR
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):159-167. PubMed ID: 31520270
[TBL] [Abstract][Full Text] [Related]
35. Clinical and microbiological characteristics of men with nonobstructive acute pyelonephritis: A multicenter retrospective observational study.
Park MG; Cho SY; Kwon SY; Choi H; Lee JW
Medicine (Baltimore); 2021 Oct; 100(40):e27386. PubMed ID: 34622842
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
Park SH; Choi SM; Chang YK; Lee DG; Cho SY; Lee HJ; Choi JH; Yoo JH
J Antimicrob Chemother; 2014 Oct; 69(10):2848-56. PubMed ID: 24928854
[TBL] [Abstract][Full Text] [Related]
37. Acute pyelonephritis in pregnancy: a retrospective study.
Sharma P; Thapa L
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):313-5. PubMed ID: 17627687
[TBL] [Abstract][Full Text] [Related]
38. Comparison of acute lobar nephronia and acute pyelonephritis in children: a single-center clinical analysis in southern taiwan.
Chen WL; Huang IF; Wang JL; Hung CH; Huang JS; Chen YS; Lee SS; Hsieh KS; Tang CW; Chien JH; Chiou YH; Cheng MF
Pediatr Neonatol; 2015 Jun; 56(3):176-82. PubMed ID: 25459491
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the efficacy and tolerance of a short 7 day third-generation cephalosporin treatment in the management of acute pyelonephritis in young women in the emergency department.
Moustafa F; Nguyen G; Mathevon T; Baud O; Saint-Denis J; Dublanchet N; Pereira B; Shinjo C; Romaszko JP; Dopeux L; Dutheil F; Schmidt J
J Antimicrob Chemother; 2016 Jun; 71(6):1660-4. PubMed ID: 26903277
[TBL] [Abstract][Full Text] [Related]
40. Selection of first-line i.v. antibiotics for acute pyelonephritis in patients requiring emergency hospital admission.
Yasufuku T; Shigemura K; Yamashita M; Arakawa S; Fujisawa M
J Infect Chemother; 2011 Apr; 17(2):231-7. PubMed ID: 20839025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]